Substance use disorder programs often use the same electronic health record, revenue-cycle system, and referral networks as other providers. Federal Part 2 confidentiality rules, however, impose protections that cannot be reduced to a generic HIPAA consent box. HHS’s 2024 final rule established a February 16, 2026 compliance date for applicable requirements. Alongside Part 2 obligations, providers should separately assess HIPAA vendor security incidents and breach-notification responsibilities.
First identify whether Part 2 applies
Coverage depends on whether the program and records fall within the federal Part 2 framework, not solely on whether the provider treats a patient with a substance use disorder. Determine which services constitute a Part 2 program, what records identify a patient as seeking or receiving those services, and where those data move.
This inventory should include scheduling tools, billing software, care coordination vendors, contractors, data warehouses, and outbound referral workflows. A policy written only for an EHR may overlook disclosures made through ordinary operations.
Consent became more aligned with treatment operations
HHS’s final rule permits a single patient consent for future uses and disclosures for treatment, payment, and healthcare operations in specified circumstances. That does not remove the special protections for use of Part 2 records in legal proceedings against patients or permit every redisclosure without analysis.
The final rule also addresses patient rights, restrictions on combining certain consents, and special consent rules for SUD counseling notes. Staff need role-based training on what kind of record and proposed use is involved.
Contracts and technology need to match the rule
Review vendor agreements, electronic consent management, redisclosure warnings and notices, patient portal settings, audit logs, and access controls. Technical ability to release a complete chart is not the same as legal authorization to disclose every segment of it.
When responding to a subpoena, law enforcement request, board investigation, or payer demand, identify the source and scope of the records. Part 2’s protections for use in proceedings against a patient are especially important; do not presume HIPAA permissions alone answer the question.
Create a defensible compliance inventory
Map the program and data flows, collect consent templates in use, test a few representative record exchanges, and document who approves unusual requests. Review whether business partners are operating under the same information-sharing assumptions the organization has written down.
The question in an audit is not whether a policy cites 42 CFR Part 2. It is whether the actual disclosure can be explained by a valid rule, consent, or recognized exception, with an auditable record of the decision.
Determine whether the records actually come from a Part 2 program
The first question is whether the entity is a federally assisted substance use disorder program within the meaning of 42 C.F.R. Part 2, or whether the organization holds records protected by that regulation. Not all information mentioning addiction or treatment receives identical protection merely because a clinician used a substance use diagnosis. A general hospital, behavioral health clinic, recovery program and downstream recipient may occupy different legal positions. Map which part of the organization created or received the records, the source of the information and any special legal authority for disclosure. A standard HIPAA notice alone cannot resolve whether Part 2 restrictions also apply.
The 2024 final rule became a 2026 operational obligation
HHS’s 2024 Part 2 final rule became subject to required compliance on February 16, 2026. Among its key changes, it permits a single consent for future treatment, payment and healthcare operations uses and disclosures, subject to detailed regulatory conditions. For HIPAA covered recipients, some redisclosures may then follow HIPAA rules. This is not a universal permission to publish patient treatment histories or provide records to any requester. Programs must consider the form, scope, expiration or revocation of consent and any applicable exception. Review old authorizations and electronic workflows against the current rule rather than assuming that a consent obtained years ago automatically satisfies every new requirement.
Legal proceedings retain heightened restrictions
Part 2 continues to restrict use of protected substance use records against a patient in civil, criminal, administrative and legislative proceedings without the required consent or appropriate court process. The newer treatment, payment and operations consent does not erase those safeguards. Additional protections also apply to separately maintained substance use disorder counseling notes. A subpoena, administrative request or law-enforcement inquiry therefore demands analysis of whether Part 2 applies, what records are sought and which legal procedure authorizes production. A provider should not assume a routine HIPAA disclosure provision answers a demand for SUD records in a proceeding against the patient.
The technology and vendor contract must mirror legal duties
Audit the EHR, patient portal, release-of-information service and business associate or qualified service organization relationships. Determine who may access protected records, whether appropriate consents are recorded and how redisclosure restrictions are communicated. The regulation does not require every Part 2 record to be physically segregated, but organizations still need reliable controls that implement legal permissions and prevent unauthorized releases. Test common use cases: a referral to another provider, disclosure to a health plan, a patient access request, a forensic audit and response to a subpoena. Preserve audit logs and the version of each authorization used for actual disclosure.
Prepare for complaints and breach reporting
HHS Office for Civil Rights now administers and enforces Part 2, and the 2026 compliance framework includes complaint procedures and breach notification requirements for unsecured protected records. Programs should maintain a documented incident-response path, identify responsible officials, train staff who handle requests and record the legal basis for every unusual disclosure. A potential violation requires a fact-specific investigation; an unauthorized access alert and a confirmed reportable breach are not necessarily the same event. Avoid blanket statements that all SUD records can now be shared like ordinary medical charts. The defensible approach is to combine carefully designed consent workflows with the continuing protections that make patients willing to seek treatment.
Sources and authorities
Need counsel on this issue? Discuss Behavioral Health Compliance or send an initial nonconfidential inquiry. BOLO Health Law is based in New Jersey; out-of-state representation is assessed under applicable rules. This article is general information, not legal advice. Contact does not establish an attorney-client relationship.